Abstract
Many mechanisms either activate or inhibit the cdks and thereby either promote or arrest progression through the mitotic cell cycle. Since the signal transduction pathways emanating from extracellular mitogens and the agents controlling these pathways are complicated there may yet be novel mechanisms of cell cycle regulation remaining to be elucidated. In this article we outline the different techniques used to study the cell cycle and its regulation. These include: establishing that the cell cycle is arrested by propidium iodide staining followed by FACS analysis or by measuring 3H-thymidine incorporation into DNA; measuring the amount of cyclin/cdk associated kinase activity; assessing the steady-state expression profiles of cyclins, cdks and ckis by immunoblotting; and investigating the formation of complexes between these proteins by coimmunoprecipitations. Caveats and advantages of each technique are discussed. Following this paradigm yielded the discovery of the cell cycle inhibitors p27Kip1 and p21Cip1 and could very well lead to the discovery or novel cell cycle regulatory mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Koff, A., Ohtsuki, M., Polyak, K., et al. (1993) Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260, 536–539.
Polyak, Kato, j. Y., Solomon, M. J., et al. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β. Genes Dev. 8, 9–22.
Firpo, E. J., Koff, A., Solomon, M. J., et al. (1994) Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14(7), 4889–4901.
Soos, T. J., Kiyokawa, H., Yan, J. S., et al. (1996) Formation of p27-cdk complexes during the human mitotic cell cycle. Cell Growth Differ. 7, 135–146.
Jiang, H., Chou, H. S., and Zhu, L. (1998) Requirement of cyclin E-cdk2 inhibition in p16Ink4a-mediated growth suppression. Mol. Cell. Biol. 18(9), 5284–5290.
Neuveut, C., Low, K. G., Maldarelli, F., et al. (1998) Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol. Cell. Biol. 18(6), 3620–3632.
Planas-Silva, M. D. and Weinberg, R. A. (1997) Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol. Cell. Biol. 17(7), 4059–4069.
Takuwa, N. and Takuwa, Y. (1997) Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17(9), 5348–5358.
Lloyd, A. C., Obermuller, F., Staddon, S., et al. (1997) Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11, 663–677.
Becton Dickinson Source Book, Section 1.11, Becton Dickinson Immunocytometry Systems, San Jose, CA, 1994.
Current Protocols in Molecular Biology, Wiley, New York.
Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245–2262.
Sambrook, J., Fritsch, E. F., and Maniatis, T. eds. (1989) Molecular Cloning—A Lab Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 7.43–7.52.
Harlow, E. and Lane, D., eds. (1988) Antibodies: A Labaratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gitig, D.M., Koff, A. Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Mol Biotechnol 19, 179–188 (2001). https://doi.org/10.1385/MB:19:2:179
Issue Date:
DOI: https://doi.org/10.1385/MB:19:2:179